Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine effect on cerebral nociceptive response in major depressive disorder assessed by fMRI
2005-003846-33Phase 4Active
- Sponsor
- Dr. NarcÃs Cardoner
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of duloxetine in major depressive disorder (MDD) (2 arms), sponsored by Dr. NarcÃs Cardoner. Primary endpoint: Change in cerebral activity before and after duloxetine treatment. Started Jan 2006; status: active.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2005-003846-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003846-33.